Form 144/A Mineralys Therapeutics, Filed by: Rodman David Malcom
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mineralys Therapeutics, Inc. (MLYS) Misses Q2 EPS by 22c
- i2Cool Launches i2Coating CorroCool, Combining Electricity-Free Cooling with Industrial-Grade Corrosion Protection
- Ambarella Announces Second Quarter Fiscal Year 2027 Earnings Conference Call to be Held September 3, 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
